REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) Plus Other Cancer Treatments for Participants With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma Interventions: Drug: REGN5458; Drug: Daratumumab; Drug: Carfilzomib; Drug: Lenalidomide; Drug: Bortezomib; Drug: Dexamethasone Sponsor: Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials